Chemotherapy Foundation 2018
Chemotherapy Foundation 2018
The Future of Chemotherapy and Patients with ER-Positive Breast Cancer
In this clip, Ruth O'Regan, MD discussed the future of chemotherapy as it relates to treating patients with breast cancer. 
Liquid Biopsy May Prove a Key Tool in Targeted Cancer Therapy
As targeted therapies for cancer continue to shape the health care landscape, health care providers may increasingly utilize liquid biopsies to identify potential treatment resistance.
Looking to the Future: Personalized Immunotherapy Combinations
Site-specific immune inflammation has been examined using intralesional injections of oncolytic viruses.
Range of Treatment Options, Precision-Based Medicine a Focus for Ovarian Cancers
In this clip, Maurie Markman, MD, discusses ovarian cancer as a chronic illness, and an increasing need for precision medicine.
Keeping Cancer on the Defensive
Former New York Giants Running Back Tiki Barber this week delivered the keynote address at the 36th Annual CFS, presented by Physicans' Education Resource, and discussed his mother's breast cancer journey. 
The Role of RTU Products in Pharmacy
In this clip, Jeffrey Lombardo, PharmD, who is the executive patient safety officer for UB’s patient safety organization Empire State Patient Safety Assurance Network, discusses the role of RTU products in pharmacy.
What Role Does the Pharmacist Play with the Oncology Care Team?
In this clip, Maurie Markman, who spoke at the CFS Symposium in NY this week, discussed the role of pharmacists in managing patients with cancer.
Melanoma Mortality Rates Across the Globe Climb for Men
Skin cancer remains the most common form of cancer in the United States, with more than 65,000 cases of melanoma estimated in 2011, according to the CDC.
The Use of RTUs in Patients with Cancer
In this video, Jeffrey Lombardo, PharmD, who is the executive patient safety officer for UB’s patient safety organization Empire State Patient Safety Assurance Network, discusses the use of RTUs in patients with cancer.
The Pharmacist's Transition to USP 800

In this clip, Jeffrey Lombardo, PharmD, who is the executive patient safety officer for University at Buffalo's patient safety organization Empire State Patient Safety Assurance Network, explains the challenges pharmacists will face in transitioning to USP800. 
 
The Challenges of USP 800 for Compounding Pharmacies
In this clip, Jeffrey Lombardo, PharmD, who is the executive patient safety officer for University at Buffalo's patient safety organization Empire State Patient Safety Assurance Network, explains the challenges compounding pharmacies will face with USP800. 
Chemotherapy Foundation 2018